 |
ACTIVE RESEARCH STUDIES
The research activities of the Division focus on four broad substantive
areas which have considerable overlap but have naturally evolved
as a result of our previous research findings, as well as the background
and expertise of our core faculty. These areas include:
Acupuncture Research
The primary goal of these studies is to develop the appropriate
methodology for evaluating this modality in order to evaluate efficacy,
safety, and mechanisms of action within the context of a variety
of clinical conditions.
Placebo Research
The primary goal for these studies is to develop a research and
scholarly agenda concerning placebo effects and controls in research
methodology. The research questions focus on all aspects of placebo,
including the extent of the effect in any particular disease, whether
the effect can be modulated, the components of the placebo response,
the basic physiological and psychological mechanisms, and whether
or not some individuals repeatedly show a placebo response.
Botanical Research
This is the newest area in which the Division will be focusing,
but one which is the closest to the model of the new NIH roadmap
in which inter-institutional and cross-disciplinary investigators
will work together to facilitate fundamental discovery and translate
that knowledge into effective preventive and therapeutic strategies.
Our work to date has concentrated on utilizing collaborative local
and international partnerships to identify and prioritize promising
herbal medicines wich can be systematically procured, extracted,
characterized, and subsequently tested in pre-clinical settings.
Ultimately, the most successful of these will be tested in multi-site
clinical trials.
Health Services Research
The primary aim of these studies is to examine directly the clinical
and cost-effectivess of individual or multi-therapy interventions
in the treatment of well-defined clinical populations (e.g., adults
with low-back pain).
Acupuncture
RO1 AT001414
Acupuncture for Irritable Bowel Syndrome
(Kaptchuk)
04/01/03-12/31/06
Little is known about acupuncture's efficacy for Irritable Bowel
Syndrome (IBS). This trial uses a manualized acupuncture treatment
format that closely follows clinical practice and allows flexibility
in designing individualized treatments. In addition, a second parallel
qualitative study will follow a subgroup of patients throughout
the trial to explore the relationships between patients' interpretations
and understandings (what anthropologists call "meaning")
of irritable bowel and their response to treatment. Cortisol levels
(an important stress hormone) will also be assessed. This will be
a 3-arm trial: Active acupuncture, placebo acupuncture, and wait
list.
Status: Recruitment initiated.
Key Personnel |
Affiliation |
| Ted Kaptchuk, OMD (PI) |
Harvard Medical School Osher Research Center |
| Roger Davis, ScD |
Beth Israel Deaconess Medical Center |
| Eric Jacobson, PhD |
Harvard Medical School-Social Medicine |
| Catherine Kerr, PhD |
Harvard Medical School-Social Medicine |
| Irving Kirsch, PhD |
University of Connecticut |
| Elvira Lang, MD |
Beth Israel Deaconess Medical Center |
| Anna Legedza, ScD |
Beth Israel Deaconess Medical Center |
| Anthony Lembo, MD |
Beth Israel Deaconess Medical Center |
| William Stason, MD |
Harvard School of Public Health |
U19 AT002022
NESA Acupuncture Research Collaborative
(Buring)
9/25/03-12/31/06
As a Developmental Center for Research in Complementary and Alternative Medicine
(DCRC), this grant brings together leaders from the oriental medicine (OM) and
conventional medicine communities to evaluate critically the efficacy and safety
of acupuncture, and develop sound methodologies and feasible study designs required
for Asian Medicine research. This project strengthens and builds upon ongoing
collaborations between the New England School of Acupuncture (NESA), the Harvard
Medical School Division and Research Center, and two other HMS-affiliated institutions,
the Dana Farber Cancer Institute and Children’s Hospital Boston. The DCRC
involves three developmental/exploratory studies (two of which focus on acupuncture
for treatment of women’s health issues) and two infrastructure cores (Administrative
and Clinical Trials).
Status: Projects initiated. Protocols finalized and IRB applications
in progress. Recruitment to begin 6/04.
Key Personnel
|
Affiliation |
| Peter Wayne, PhD (PI) |
New England School of Acupuncture |
| Julie Buring, ScD (HMS PI) |
Harvard Medical School Osher Research Center |
| Sally Andrews, MBA |
Harvard Medical School Osher Research Center |
| Lisa Conboy, ScD |
Harvard Medical School Osher Research Center |
| Ellen Connors |
MA New England School of Acupuncture |
| Roger Davis, ScD |
Beth Israel Deaconess Medical Center |
| Elizabeth Dean-Clower, MD |
Dana-Farber Cancer Institute |
| Anne Doherty, MPH |
Dana-Farber Cancer Institute |
| James Griffin, MD |
Dana-Farber Cancer Institute |
| Andrea Hrbek |
Harvard Medical School Osher Research Center |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
| Catherine Kerr, PhD |
Harvard Medical School-Social Medicine |
| Alice Kornblith, PhD |
Dana-Farber Cancer Institute |
| Marc Laufer, MD |
Children’s Hospital Boston |
| Hang Lee, PhD |
Dana-Farber Cancer Institute |
| Anna Legedza, ScD |
Beth Israel Deaconess Medical Center |
| Zhi Ping Li, MB, MA |
New England School of Acupuncture |
| Weidong Lu, MB, MPH |
New England School of Acupuncture |
| Ursula Matulonis, MD |
Dana-Farber Cancer Institute |
| Patrick McKnight, PhD |
New England School of Acupuncture |
| Richard Penson, MD |
Dana-Farber Cancer Institute |
| David Rosenthal, MD |
Dana-Farber Cancer Institute |
| Steven Schachter, MD |
Harvard Medical School Osher Research Center |
| Rosa Schnyer, Dipl. Ac. |
New England School of Acupuncture |
| Edward Thomas, MBA |
New England School of Acupuncture |
Botanicals
Starr Foundation
Evaluating East Asian Herbs for Their
Chemo-preventive, Chemo-therapeutic Potential (Eisenberg)
11/1/03 - 05/31/06
This project tests a research strategy
and protocols for the purchase, extraction, fractionation, and characterization
of compounds with potential chemo-therapeutic and chemo-preventive
properties. The results from this study will provide pilot data
and procedures to be used in an NIH program project or specialized
center of research grant (P-50).
Status: Forty-five herbs have been extracted and fractionated
and are currently undergoing high throughput bioassay screening
within the ICCB at HMS.
Key Personnel
|
Affiliation
|
| David Eisenberg, MD (PI) |
Harvard Medical School Osher Research Center |
| Jon Clardy, PhD |
Harvard Medical School-Biological Chemistry &
Molecular Pharmacology |
| Ted J. Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
| Steven Schachter, MD |
Harvard Medical School Osher Research Center |
| David Lee, PhD |
McLean Hospital |
The Epilepsy Cure (Fndtn)
Asian Herbs for Epilepsy (Schachter)
3/1/04-2/28/05
The specific aims of this grant are to: 1) systematically procure,
extract, and characterize herbal medicines identified as promising
for epilepsy; 2) to test these well-characterized herb extractions
in validated animal models of epilepsy, and 3) to submit those herb
extractions with anti-seizure properties (as demonstrated by the
animal studies) to high-throughput screening to evaluate for biological
activity.
Status: Testing in completed and analysis is ongoing.
Key Personnel
|
Affiliation
|
| Steven Schachter, MD (PI) |
Harvard Medical School Osher Research Center |
| David Eisenberg, MD |
Harvard Medical School Osher Research Center |
| Julie Buring, ScD |
Harvard Medical School Osher Research Center |
| Michael Cohen, JD |
Harvard Medical School Osher Research Center |
| David Lee, PhD |
McLean Hospital |
| Jon Clardy, PhD |
Harvard Medical School-Biological Chemistry & Molecular
Pharmacology
|
Health Services and Clinical Trials
R21 AT002564
Patient Variables and Placebo Response
in IBS (Ablon)
9/01/05-7/31/07
Research on whether patient psychological and personality variables
can predict placebo response has been inconclusive and contradictory.
Part of the problem in identifying and validating these patient
variables arises out of the methods used to assess them. In particular,
prior investigations have assessed these variables in isolation
from the patient-practitioner relationship, often via self-report
personality questionnaires taken at baseline. The approach in this
study is unique in that we will study patient variables not in isolation
but rather in context, as they manifest themselves during a clinical
encounter. We hypothesize that the important patient factors influencing
placebo response are not to be found in global measures of personality
in general nor in attitude measures collected just prior to treatment,
but rather in specific measures of the interpersonal process that
occurs between a particular patient and a particular practitioner
at a particular point in time.
Status: This study will use data generated in an earlier trial which
has just completed recruitment.
Key Personnel |
Affiliation |
| Stuart Ablon, PhD |
Massachusetts General Hospital |
| Lisa Conboy, ScD |
Harvard Medical School Osher Research Center |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
| John Kelly, PhD |
Massachusetts General Hospital |
R01 AT002454
Tai Chi Mind-Body Therapy for Chronic Heart
Failure (Yeh)
9/29/04-6/30/07
This study will examine Tai Chi, a meditative mind-body exercise
form that has not yet been rigorously studied in patients with heart
failure despite increasing popularity among the general public.
Exercise has only recently been recognized as an important component
of conventional HF management. Optimal protocols have not yet been
defined in this population. Existing clinical trials focus solely
on physical exercise that has no mindful component, such as treadmill
or bicycle training. Tai Chi, however, may have advantages over
conventional exercise forms and be particularly suited to frail,
de-conditioned patients. With origins in Chinese healing and martial
arts, Tai Chi incorporates both slow, gentle physical activity with
meditation, relaxation and self-awareness and can be easily performed
by chronically ill individuals with HF.
The primary goal of our proposed research is to determine the potential
benefit of a tailored 12-week Tai Chi exercise program on functional
capacity and health related quality-of-life in patients with chronic
HF. The overarching secondary goal is to begin to understand the
mechanisms underlying any beneficial effect of Tai Chi. Through
exploration of various physiologic and metabolic pathways and behavioral/
psychosocial indices, we will be in a better position to design
future mechanistic studies. In addition, this study will provide
necessary data to analyze the cost implications for Tai Chi as adjunctive
therapy for HF.
Status: Study has just started recruitment.
Key Personnel |
Affiliation |
| Russel Phillips, MD |
Beth Israel Deaconess Medical Center |
| Gloria Yeh, MD, MPH |
Harvard Medical School Osher Research Center |
| David Eisenberg, MD |
Harvard Medical School Osher Research Center |
| Roger Davis ScD |
Beth Israel Deaconess Medical Center |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
R01 AT00905
Model of Integrative Care in an Academic
Health Center
(Eisenberg)
9/25/01-6/30/06
The purpose of this application is to develop a replicable model
of integrative care within an academic medical center in order
to plan subsequent controlled trials. It is intended to serve as
a prototype to be refined and replicated at other hospitals regionally
and nationally. The four aims of the project include:
1. Development of strategies procedures (i.e. credentialing, liability,
pharmacy and therapeutics guidelines, data tracking, billing, administrative
requirements) necessary to open an integrative care center within
an academic health center.
2. To implement and refine these strategies in the operation of
an integrative care clinical facility within an academic health
center (BWH);
3. To demonstrate our ability to evaluate the effectiveness of
care provided by the Integrative Care Center in a pilot RCT involving
subjects with persistent low back pain;
4. To review the results of our pilot study to design a subsequent
full-scale trial with adequate statistical power; to summarize
the cost of building and sustaining this model; and, to document
our strategies and disseminate our procedures, enabling transfer
and refinement of the model at other sites.
Status: Policies and procedures have been developed. A hospital
partner has been identified (i.e. BWH). The clinician team has been
identified and has participated in training over the last eight
months. An RCT (n=60) has been designed and approved by the Partner’s
IRB and has been initiated.
Key Personnel |
Affiliation |
| David Eisenberg, MD (PI) |
Harvard Medical School Osher Research Center |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
| Michael Cohen, JD |
Harvard Medical School Osher Research Center
|
| Russ Phillips, MD |
Beth Israel Deaconess Medical Center |
| Maureen Connelly, MD |
Harvard Pilgrim/Harvard Vanguard |
| Roger Davis, ScD |
Beth Israel Deaconess Medical Center |
| Andrea Hrbek, BA |
Harvard Medical School Osher Research Center |
| Donald Levy, MD |
Harvard Medical School Osher Research Center |
| Sally Andrews, MBA |
Harvard Medical School Osher Research Center |
| Mark Cunningham |
Harvard Medical School Osher Research Center |
1R21 CA098487
Massage for Hospitalized Patients with
Metastatic Cancer
4/1/04-3/31/06
Symptoms such as pain and nausea are common among patients with
metastatic cancer, and symptom control is often inadequate. Massage
therapy has been advocated as adjunctive therapy in the management
of cancer related pain, but has received little careful study. Our
study will enroll 100 patients admitted to the hospital with metastatic
cancer and randomize them to receive massage therapy, a sham massage
control, or usual care while in the hospital. Following completion
of the hospital-based data collection, half of subjects with caregivers
will be randomized to receive instruction to enable caregivers to
provide massage for patients at home. We will collect data from
patients and caregivers to determine the impact of hospital-based
massage therapy and home-based caregiver massage on cancer-related
symptoms and quality of life.
Status: Study is in recruitment.
Key Personnel |
Affiliation |
| Russel Phillips, MD |
Beth Israel Deaconess Medical Center |
| Janet Kahn, LMT, PhD |
Peace Village Projects |
| Roger Davis ScD |
Beth Israel Deaconess Medical Center |
Education
T32 AT000051
Research Training: Complementary and Integrative
Medicine (Phillips)
9/30/99-7/31/09
In 2003 Harvard Medical School's NIH fellowship training
grant for training in integrative medicine was renewed for a second
five-year term. Although academic centers devoted to CAM research
have been funded, there is a shortage of trained clinical investigators
with interest and expertise in CAM modalities. Therefore, NIH-funding
training programs are required to prepare trainees for research
careers in the field. This program is the first post-doctoral fellowship
in CAM research to be based at Harvard MedicalSchool. The program
has graduated sex MD Fellows to date, all of whom have moved on
to research positions at academic centers or positions combining
clinical and research training.
Key Personnel |
Affiliation |
| Russel Phillips, MD |
Beth Israel Deaconess Medical Center |
| Sally Andrews, MBA |
Harvard Medical School Osher Research Center |
| David Eisenberg, MD |
Harvard Medical School Osher Research Center |
| Roger Davis ScD |
Beth Israel Deaconess Medical Center |
K23 AT002624
BioMind-Body Exercise in the Management
of Cardiac Disease (Yeh)
2/01/05-1/31/10
This career development award Dr. Yeh in acquiring additional research
skills and experience under the mentorship of nationally and internationally
known researchers in a supportive academic environment. Collectively,
the three related projects in this proposal will allow her to further
focus her research efforts on cardiovascular disease and complementary
therapies.
Key Personnel |
Affiliation |
| Gloria Yeh, MD, MPH |
Harvard Medical School Osher Research Center |
| Russel Phillips, MD |
Beth Israel Deaconess Medical Center |
| Julie Buring, ScD |
Brigham and Women's Hospital |
| Ari Goldberger, MD |
Beth Israel Deaconess Medical Center |
| David Eisenberg, MD |
Harvard Medical School Osher Research Center |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
K23 AT003238
Biophysics of Acupuncture: Electrical Properties
of Loose CT (Ahn)
9/30/05-9/29/10
This career development proposal supports a long-term inquiry in
the biophysical nature of acupuncture meridians and points. This
proposal is driven by the hypothesis that electrical signals through
loose connective tissue are responsible for communications occurring
in the acupuncture network. Recent studies have shown that acupuncture
meridians correspond to connective tissue planes. While the anatomical
correlation has been made, the physiological significance of this
association is unclear. Elucidating the mechanisms underlying these
properties may greatly enhance our understanding of acupuncture’s
clinical effects.
Key Personnel |
Affiliation |
| Andrew Ahn, MD, MPH |
Harvard Medical School Osher Research Center |
| Russel Phillips, MD |
Beth Israel Deaconess Medical Center |
| Alan Grodinsky, ScD |
Massachusetts Institute of Technology |
| Helene Langevin, MD |
University of Vermont Medical School |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
Completed Studies
RO1 AT00622
Physical CAM Therapies for Chronic Low
Back Pain
(Eisenberg)
9/1/00-6/30/04
This study evaluates the relative effectiveness and costs of the
three most commonly used physical CAM therapies (acupuncture, chiropractic,
and massage) for both older and younger adults with chronic low
back pain. Phase I involved testing and refining the components
of a randomized clinical trial evaluating acupuncture, chiropractic
and massage for chronic low back pain including specification of
treatment and comparison groups, subject selection criteria, recruitment
and retention strategies, and development of instruments for measuring
outcomes. During Phase II, a pilot study, using the findings from
Phase I, was conducted to evaluate the three physical CAM treatments.
Results of the pilot study will be used to identify unanticipated
problems and to estimate the sample sizes required for an adequately
powered full-scale trial.
Status: Study complete. Analysis is ongoing.
Key Personnel |
Affiliation |
| David Eisenberg, MD |
Harvard Medical School Osher Research Center |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
| Dan Cherkin, PhD |
Group Health Cooperative of Puget Sound |
| Roger Davis ScD |
Beth Israel Deaconess Medical Center |
| Maureen Connelly, MD, MPH |
Harvard Pilgrim/Harvard Vanguard |
| Karen Sherman, PhD |
Group Health Cooperative |
RO1 AT00607
Optimizing Therapeutic Ratios for Herbs
(Goldman)
9/1/00-6/30/05
The goal of this proposal is to investigate whether ginkgo may
interact with such prescribed anticoagulants as warfarin and ticlopidine
at the level of the cytochrome P450 system. Additional studies will
determine which fractions of ginkgo are responsible for its anti-platelet
effects and how these fractions relate to ginkgo’s non-specific
antioxidant effects, which many believe are responsible for ginkgo’s
benefits. By addressing the issues of herbal product consistency
and using laboratory models to define chemical and biological mechanisms
of potential clinical significance, this proposal offers a paradigm
for the multidisciplinary study of commonly used herbal products.
Status: This project is completed and papers are now being authored.
Key Personnel |
Affiliation |
| Peter Goldman, MD (PI) |
Harvard Medical School Osher Research Center |
| Ted Kaptchuk, OMD (PI) |
Harvard Medical School Osher Research Center |
| Ikhlas Khan, PhD |
University of Mississippi |
| David Greenblatt, MD |
Tufts University School of Medicine |
R21 AT001979-01
US-China-Japan Research Consortium on Herbal
Medicines
(Eisenberg)
09/25/03 - 03/31/05
This planning grant has the long-term goal of developing an International
Center for CAM Research focused on the systematic evaluation of
East Asian herbal medicines.
Status: Regular conference calls are held among consortium members
to: 1) prioritize top candidate herbs; 2) develop/refine existing
protocols to Perform Bioassays/HST evaluations; 3) plan for the
Phase II grant submission and clinical trial development.
| Key Personnel
|
Affiliation |
| David Eisenberg, MD (PI) |
Harvard Medical School Osher Research Center |
| Julie Buring, ScD |
Harvard Medical School Osher Research Center |
| Paul Hays But, PhD |
Chinese University of Hong Kong |
| Ke-Ji Chen, MD |
China Academy of Traditional Chinese Medicine
|
| Jon Clardy, PhD |
Harvard Medical School-Biological Chemistry &
Molecular Pharmacology |
| Michael Cohen, JD |
Harvard Medical School Osher Research Center |
| James Feinerman, MD |
Georgetown University School of Law |
| Sherman Kowk-Wing Fung, PhD |
Chinese University of Hong Kong |
| Saishan Guo, MD |
Chinese Academy of Medical Sciences |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
| P.C. Leung, MD |
Chinese University of Hong Kong |
| Gregg Plotnikoff, PhD |
Keio University |
| Han Rui, MD |
Chinese Academy of Medicine |
| Steven Schachter, MD |
Harvard Medical School Osher Research Center |
| Catherine E Shamu, PhD |
Harvard Medical School |
| Jun Song, MD |
China Academy of Traditional Chinese Medicine |
| Kenji Watanabe, MD, PhD |
Keio University |
RO1 AT001414
Usual Care Vs Choice of Alternative Rx:
Low Back Pain (Eisenberg)
9/30/99-8/31/03
This study compares two approaches to the management of acute low
back pain: usual care (standard benefit) vs. the choice of: usual
care, chiropractic, acupuncture or massage therapy (expanded benefit).
The results of this randomized trial of 44 subjects will provide
valuable information to clinicians, patients and third party payers
on the relative benefits and costs of an "expanded benefits"
treatment option which incorporates chiropractic, acupuncture and
massage services for low back pain.
Status: Study complete. Analysis is ongoing.
Key Personnel |
Affiliation |
| David Eisenberg, MD |
Harvard Medical School Osher Research Center |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
| Russell Phillips, MD |
Beth Israel Deaconess Medical Center |
| Roger Davis ScD |
Beth Israel Deaconess Medical Center |
| Maureen Connelly, MD, MPH |
Harvard Pilgrim/Harvard Vanguard |
| Dan Cherkin, PhD |
Group Health Cooperative of Puget Sound |
| Diana Post, MD |
Brigham and Women's Hospital |
| Anna Legedza, ScD |
Harvard Medical School Osher Research Center |
| Julie Buring, ScD |
Harvard Medical School Osher Research Center |
| Andrea Hrbek, BA |
Harvard Medical School Osher Research Center |
| Lisa Prosser, PhD |
Harvard Pilgrim/Harvard Vanguard |
G13 LM07575 (NLM)
Legal and Social Barriers to Alternative
Medicine
(Cohen)
1/15/02-12/31/04
The project will result in a scholarly, book-length manuscript
that critically evaluates the integration of complementary and alternative
medical (“CAM”) therapies into conventional medical
settings in the United States. Methods have included a critical
review of literature and interviews with key personnel in existing,
integrated health care centers, regarding the development of their
practices and the problems they have encountered. Such a study aims
to fill a gap in the current health care literature by collecting
the kind of information needed to develop, sustain and evaluate
critically the evidence-based clinical integration of CAM therapies
in conventional medical settings.
Status: Interviews completed. Draft book manuscript in process.
Key Personnel |
Affiliation |
| Michael Cohen, JD (PI) |
Harvard Medical School Osher Research Center |
| Mary Ruggie, PhD |
Harvard University-Kennedy School of Government |
| David Eisenberg, MD |
Harvard Medical School Osher Research Center |
| Ted Kaptchuk, OMD |
Harvard Medical School Osher Research Center |
RO1 AT00402
Sham Device, Pill Placebo Or Treatment
For Arm Pain (Kaptchuk)
09/01/00-06/30/04
Status: Recruitment and data collection completed. Analysis is ongoing.
A draft manuscript has been submitted.
| Key Personnel |
Affiliation |
| Ted Kaptchuk, OMD (PI) |
Harvard Medical School Osher Research Center |
| Rose Goldman, MD |
Cambridge Health Alliance |
| William Stason, MD |
Harvard School of Public Health |
| Roger Davis, ScD |
Beth Israel Deaconess Medical Center |
|
 |